Any disease that impairs the functioning of the muscles, either directly, being pathologies of the voluntary muscle, or indirectly, being pathologies of nerves or neuromuscular junctions
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Connect with organizations supporting the neuromuscular disease community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning neuromuscular disease
Updated Jan 26, 2026
The Muscular Dystrophy Association (MDA) is celebrating Rare Disease Day on February 28 by sharing community stories that highlight advancements in research, care, and advocacy for individuals with rare neuromuscular diseases. This initiative aims to enhance awareness and engagement among those affected by muscular dystrophy, ALS, and related conditions.